Objective evaluation of changes in lens clarity after repeated injections of ranibizumab in patients with neovascular age-related macular degeneration

ALTUNEL O., GÜLTEKİN IRGAT S., ÖZCURA F.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, vol.260, no.9, pp.2897-2904, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 260 Issue: 9
  • Publication Date: 2022
  • Doi Number: 10.1007/s00417-022-05668-9
  • Journal Name: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.2897-2904
  • Keywords: Cataract, Lens densitometry, Ranibizumab, Scheimpflug imaging, ENDOTHELIAL GROWTH-FACTOR, CHOROIDAL NEOVASCULARIZATION, OPACITIES, SYSTEM, REPEATABILITY, VERTEPORFIN
  • Kütahya Health Sciences University Affiliated: Yes

Abstract

Purpose To objectively evaluate changes in lens densitometry in eyes with neovascular age-related macular degeneration (n-AMD) treated with repeated intravitreal ranibizumab injections during a 12-month period and to compare the results with those in untreated healthy fellow eyes and healthy control eyes.